Healthcare
Live Price
Offline$0.498
+0.00% today
1Y Change
-13.98%
Window
Jun 23, 2025 → Jun 4, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 4, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Vynleads, Inc. (VYND) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.50 and down 14.0% across the available one-year price window (Jun 23, 2025 → Jun 4, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +31.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +31.9%, free cash flow +3.1% with operating margin 0.0% and ROIC 132.2%. Stock Foundry combines VYND price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VYND
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VYND Max Drawdown
-49.59%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VYND and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$484.0
+887.8% YoY
FY Net Income
-$282.6K
-3.3% YoY
Free Cash Flow
-$130.5K
-5.5% YoY
Revenue Growth
+0.0%
EPS Growth
+31.9%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 49 | 484 |
| Gross Profit | -6K | -15K | -36K | -29K | -32K |
| Operating Income | -247K | -239K | -236K | -261K | -267K |
| EBITDA | -247K | -239K | -236K | -254K | -254K |
| Net Income | -255K | -261K | -263K | -274K | -283K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 45K | 69K | 15K | 503 | 2K |
| Total Assets | 54K | 87K | 36K | 24K | 25K |
| Total Liabilities | 406K | 315K | 805K | 660K | 517K |
| Shareholder Equity | -352K | -227K | -769K | -635K | -492K |
| Total Debt | 165K | 81K | 528K | 369K | 250K |
| Net Debt | 121K | 12K | 513K | 369K | 249K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
131K
-5.5% YoY
Capital Expenditures
0
Free Cash Flow
131K
-5.5% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
81.3%
Debt / Equity
-0.47x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.